Citadel Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Sell |
527,288
-1,538,488
| -74% | -$55.4M | ﹤0.01% | 991 |
|
|
2025
Q1 | $64.3M | Sell |
2,065,776
-832,188
| -29% | -$25.9M | 0.01% | 387 |
|
|
2024
Q4 | $73.9M | Buy |
+2,897,964
| New | +$73.9M | 0.01% | 370 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6567 |
|
|
2024
Q2 | – | Sell |
-97,919
| Closed | -$2.97M | – | 6679 |
|
|
2024
Q1 | $2.97M | Sell |
97,919
-389,101
| -80% | -$11.8M | ﹤0.01% | 2155 |
|
|
2023
Q4 | $13.7M | Buy |
487,020
+363,939
| +296% | +$10.2M | ﹤0.01% | 1048 |
|
|
2023
Q3 | $3.34M | Sell |
123,081
-532,291
| -81% | -$14.4M | ﹤0.01% | 1949 |
|
|
2023
Q2 | $20.1M | Sell |
655,372
-423,582
| -39% | -$13M | ﹤0.01% | 816 |
|
|
2023
Q1 | $38.9M | Buy |
1,078,954
+567,014
| +111% | +$20.4M | 0.01% | 551 |
|
|
2022
Q4 | $20.2M | Buy |
511,940
+175,979
| +52% | +$6.95M | ﹤0.01% | 866 |
|
|
2022
Q3 | $13.5M | Buy |
335,961
+76,116
| +29% | +$3.06M | ﹤0.01% | 1072 |
|
|
2022
Q2 | $10.9M | Sell |
259,845
-1,323,288
| -84% | -$55.6M | ﹤0.01% | 1214 |
|
|
2022
Q1 | $61.7M | Buy |
1,583,133
+1,371,252
| +647% | +$53.4M | 0.01% | 354 |
|
|
2021
Q4 | $8.44M | Buy |
211,881
+99,702
| +89% | +$3.97M | ﹤0.01% | 1607 |
|
|
2021
Q3 | $4.05M | Sell |
112,179
-377,172
| -77% | -$13.6M | ﹤0.01% | 2229 |
|
|
2021
Q2 | $20.1M | Buy |
489,351
+351,746
| +256% | +$14.4M | ﹤0.01% | 957 |
|
|
2021
Q1 | $6M | Sell |
137,605
-186,636
| -58% | -$8.14M | ﹤0.01% | 1882 |
|
|
2020
Q4 | $16.2M | Buy |
324,241
+256,692
| +380% | +$12.8M | ﹤0.01% | 971 |
|
|
2020
Q3 | $2.84M | Sell |
67,549
-856,056
| -93% | -$36M | ﹤0.01% | 1957 |
|
|
2020
Q2 | $44.8M | Buy |
+923,605
| New | +$44.8M | 0.02% | 413 |
|